Member Info for Aldebaran

Im just trying to stay grounded. Nothing new in this RNS really. The FDA had already approved pediatrics and everyone believed dose expansion would be forthcoming so I just feel its news we already know. Well, apart from the team helping themselves to 6,000 more shares but what's a bit of dilution here or there for hemo. Par for the course.

Come on Vlad, give us some forward looking statements and objectives we can measure you against. Currently operating with impunity and protected by a wall of sheep on here

The problem is, you have been recommending this as a buy every day at every price forever. You cant now say that you are some Oracle and called it as a buy at that price and pat yourself on the back.

Anyway what do you lot expect to happen here? You are all already convinced this is the best thing since sliced bread and safety approval was a given therefore I suggest this update is priced in. Am I wrong? So far seems not. Let's see what next few sessions bring.

As for your statement about there being no better investment in the coming days weeks months years i mean where to even start with that BS. the hyperbole and ramping is of the scales.

How many other companies have you researched to confidently make that statement? How many comparable small cap biotechs even? 3, 2 l, 1, none? Is it none?

I think its none. You just love hemo

Call me all you like lol

Im expressing a opinion on a investor bulletin board. Just because it isnt overtly positive and I dont follow hype doesn't make it any less valid or true. Indeed the market isnt exactly racing ahead now is it.

Still need to wait for recruitment and then dosing and then 30 days safety review etc.. clock is ticking no visibility on timelines again. As always.

So now we have to wait how long for recruitment?

See the hemo team have treat themselves to a shed load more shares as well. Why you lot getting a hard on about this update is beyond me. Its priced in to a large extent.

What if talks started with one goal in mind but after a deeper look those talks have evolved into something deeper? Quite possibly id say hence the raise. There is definitely plenty of options here the optionality is enormous. Im comfortable with raise just behind us, no cln to hold us back and still loads of news to come. Think we get an take over offer lot soon than people think and that then sets off a chain reaction of bids.

In it to win it Rodders

Fair post that. No objection from me. This is what these boards are for.

Now i want vlad to build on this and drive value going forward. Is that also fair?

He needs to be more communicative with shareholders and allow Q&A etc.. its not hard or even costly. You have his ear JHFH. I want the company to succeed. Despite being negative I hope you see that.

Anyway, great post thanks for the debate

Vlad almost run this company into the ground. It was on fumes and needed more money. If it wasn't for JHFH & his mates approaching Vlad, the company was at very real risk of going bust.

Me having a pop on a investor bulletin board is hardly going to have ANY impact on getting potentially life saving treatment to kids so spare me the faux outrage. Vlad has done more value destruction than anyone here combined and he's still doing it.

He knew that the SP would rally strongly on funding news at a premium, he knew there was good trial results coming or he had a informed inclination let's put it that way, he knew he was going to DC & NYC, he knew he was in negotiations with Celline etc.. he knew the SP would rise so he should of had a plan to capitalise on that with a raise OR at least attempt to maintain the valuation with some level of investor relations. All weve had is a half assed proactive interview its pathetic. No Q&A no nothing. 60% value has been lost here in a matter of weeks. 60%.

We dont know if the patience are still alive. We dont know when the safety team are even meeting to review safety data we dont know when we can expect an update on Estonia or what the next steps are, we know FA and because of that uncertainty value is once again eroded so any good news now will see us struggle to get passed recent highs. This company i believe is undervalued grossly and I seem to be the only one who gives a fk about it.

You've all lost objectivity here completely. All hail vlad. Go hemo go. Its a fan club this not a serious investor discussion bored.

Also regarding avacta, come back when you've realised what the TAM is for 90% of all solid tumours and the chance of success and compare the upside to hemo and tell me hemo is a better risk reward. Spoiler alert its noway near

Perhaps I'll miss the bottom but if the upside is as big as expected then ill still make large enough gains so im happy with that. I cant mentally and financially afford to take any more risk with AFC. When I see the sales in the accounts ill be much happier. A lot could go wrong you see and usually does take longer than anyone plans. Im comfortable with Avacta now in a uptrend so im making money there which I'll be looking to put in here if the the turnaround materialises

Orders Daz yes. Order books blah blah blah.

Shown me the booked revenue and pathway to profitability then ill start to believe. Bin let down to many times here. Its a show me story now im afraid. Also I think John has a lot of credibility. I think he will turn this around but it'll take time and money also need to factor in delay risks unforseen issues etc... the market cap here is already quite high and they will need more money next year for certain.

This is why I believe 2027 will be a great time to reevaluate here and if things HAVE turned around it'll be a decent risk reward. Right now its just buying and hoping trying to time the bottom.

Theirs one thing saying they can provide hydrogen at say cost parity with diesel but its another thing delivering it.

The market cap of afc energy already has the tech working priced in IMO. Now is a matter of proving they can actually make some sizeable sales. We'll know for certain in 2027.

Another raise next year first though

Stop. Engaging. With. The. Parasite. When will you lot learn

Lol

Care to back up those numbers with, ya know, facts or calculations?

Maybe no partnerships of licence comes. We have enough money to get 6103 results. Enough said.

Offer lands when they are in and even before potentially. P1b next month.

Perhaps share price doesn't run up or anything happen other than buyout offer out the blue. Which then sparks a bidding war with shares suspended. Wouldn't that be nice for us all

Reclaimed the 50ma today which is good. One more day (3 in total below) and id have been derisking a tad. Let's see where it closes. Above 900p ideally

LONDON and PHILADELPHIA - 20 October 2025 - Avacta (AIM: AVCT), a clinical stage biopharmaceutical company developing pre|CISION®, a unique oncology delivery platform, is pleased to announce that it has raised gross proceeds of approximately £16 million from INSTITUTIONAL and high net worth investors by way of a conditional oversubscribed placing of 25,396,806 new ordinary shares

Because timelines drift. They ALWAYS drift. Even if they don't drift then we won't see results of sales until 2027 accounts. Nobody believes afc anymore. Remember the contracted order book for over 20m in sales... what happened to that?

No, im afraid we need to see the money coming in via a PL cash flow and balance sheet statements in 2027

Wear all waiting with baited breath mate.

Not.

2027 is when any transformation will be evidenced

AVA6000?

JHFH we shouldn't have to guess what Vlad has going on behind the scenes. This is a PLC. There should be a roadmap which we can hold him to and measure progress against. What if all these plans he has doesn't come off how would we ever know and judge him? He works for us remember. We own this company. Shareholders. He's accountable to us and yet he operates in the dark. This past couple of months as seen 60% of the value of this company eroded. 60%. When it hadn't even re rated to anything like fair value at 1600p either so it was undervalued then.

Hemo will need money in the new year without a commercial deal. Please dont lecture me on the non binding letter of intent for liminal patience in eastern Europe. He needs cash and he'll have to come to the market as even you and your mates cant fund hemo forever plus help develop CBR and so on. So I want the company value UP in order to give less dilution and more flexibility. There as already been a 400-1 share consolidation for crying out loud. The valuation of the company needs managing by a market sensitive commercially savvy CEO. Right now we dont have that and its costing us future returns. More than people realise. A lot more. If Vlad starts making better decisions and communicating properly with shareholders ill be first to praise him, as I will if the science continues to impress. Right now despite your assurances this feels and acts a lot like same old hemo.

Archbishopholmes as ive repeatedly said you are absolutely right. I am pleased you haven't changed your view on avacta and dont understand the results. Please continue in your ignorance and yes I brought avacta up today and why not. After all your all philanthropist here right investing for patient benefit and want to see cancer cured right? Surely the avacta news today is relevant to you all right?

If u bother to look back at the last 10 or so times avact was discussed on this board you would find it was others raising it in a negative way wanting to draw me in. You reap what you sow.

Back to hemo, if I may, I still think Vlad should of raised and had a plan to raise. This just feels like a rudderless ship. Next update needs to be blockbuster telling us safety committee are more than happy with what they've seen. Dosing will be within X days for adults and pediatrics and give an update on the health of existing trial patience. If he does that and all the answers are positive you'll find I won't be able to sing hemo praises loud enough in terms of scientific achievement. I want this to succeed, it looks promising so far. If only we had a commercially astute CEO